General description
Emtricitabine + tenofovir is a fixed-dose combination of nucleotide/nucleoside analog reverse-transcriptase inhibitors (NRTIs) used to prevent and treat HIV/AIDS.
INN
Emtricitabine + tenofovir
ATC codes
Medicine type
Chemical agent
EML status history
First added in 2007
(TRS
946)
for
Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified
Added in 2017
(TRS
1006)
for
Contact with or exposure to human immunodeficiency virus
Wikipedia
DrugBank
Recommendations
Section
Fixed-dose combinations of antiretrovirals
- Oral > Solid: 200 mg + 300 mg (tenofovir disoproxil fumarate equivalent to 245 mg tenofovir disoproxil)